What is Skye Bioscience, Inc. Common Stock's Market Cap?

Skye Bioscience, Inc. Common Stock's Market Cap is $66.6M, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's Enterprise Value?

Skye Bioscience, Inc. Common Stock's Enterprise Value is $56.5M, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's EV / EBITDA?

Skye Bioscience, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's Net Income (TTM)?

Skye Bioscience, Inc. Common Stock's Net Income (TTM) is -$50.5M, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's EBITDA?

Skye Bioscience, Inc. Common Stock's EBITDA is -$51.2M, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's Diluted EPS (TTM)?

Skye Bioscience, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.

What is Skye Bioscience, Inc. Common Stock's Net Debt?

Skye Bioscience, Inc. Common Stock's Net Debt is -$10.1M, based on as-reported figures from SEC (XBRL) filings.

Skye Bioscience, Inc. Common Stock (SKYE) Financial Statements

Skye Bioscience, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00433H0D8

XNAS · usd

1.88▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.88

Day's Range1.80 – 1.97

52-Week Range0.26 – 4.99

Volume105.6K

Avg Volume644.3K

Share Statistics

Shares Outstanding

Employees12

ExchangeXNAS

Listed2014-02-24

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Skye Bioscience, Inc. Common Stock (SKYE)

What is Skye Bioscience, Inc. Common Stock's Market Cap?: Skye Bioscience, Inc. Common Stock's Market Cap is $66.6M, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's Enterprise Value?: Skye Bioscience, Inc. Common Stock's Enterprise Value is $56.5M, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's EV / EBITDA?: Skye Bioscience, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's Net Income (TTM)?: Skye Bioscience, Inc. Common Stock's Net Income (TTM) is -$50.5M, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's EBITDA?: Skye Bioscience, Inc. Common Stock's EBITDA is -$51.2M, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's Diluted EPS (TTM)?: Skye Bioscience, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.
What is Skye Bioscience, Inc. Common Stock's Net Debt?: Skye Bioscience, Inc. Common Stock's Net Debt is -$10.1M, based on as-reported figures from SEC (XBRL) filings.